Company Analysis

Lisata Therapeutics, Inc. (LSTA)

Nasdaq: LSTA · Pharmaceutical Preparations · Basking Ridge, NJ · filing with the SEC since 1995
Grade4.2
◀ Past 3.8● Present 4.5▶ Future 4.2
2 est.

Filings

302 filings since 2017 beside 153 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Oct 19, 2026.

Filings a yearinsider forms included
3352525627322763
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Nov 9, 2026.SEC letters: 2 in the last 36 months, the newest May 7, 2024.
Insider forms 153

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 S-3 Shelf registration
Nov 12, 2026 S-8 Employee stock plan registration
Nov 12, 2026 8-K/A item 9.01 Financial statements and exhibits · Current report, amended Sep 17, 2026
Nov 9, 2026 DEFA14A Extra proxy material
Nov 9, 2026 8-K items 5.02, 5.07, 8.01, 9.01 Officer or director change; Shareholder vote; Other event · Current report
Oct 19, 2026 ARS Annual report to shareholders Dec 31, 2025
Oct 19, 2026 DEF 14A Proxy statement Nov 9, 2026
Oct 14, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Oct 13, 2026
Oct 7, 2026 PRE 14A Preliminary proxy statement Nov 9, 2026
Oct 2, 2026 D Private placement notice
Aug 26, 2026 SCHEDULE 13G Large holder notice
Aug 6, 2026 10-Q Quarterly report Jun 30, 2026
Aug 4, 2026 8-K items 2.05, 5.02, 8.01, 9.01 Exit or restructuring costs; Officer or director change; Other event · Current report Aug 3, 2026
Jul 28, 2026 SC TO-T/A Tender offer, amended
Jul 24, 2026 8-K items 1.02, 8.01 Major agreement ended; Other event · Current report
Jul 21, 2026 SC 14D9/A Response to a tender offer, amended
Jul 17, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Jul 16, 2026
Jul 17, 2026 SC 14D9/A Response to a tender offer, amended
Jul 17, 2026 SC TO-T/A Tender offer, amended
Jul 13, 2026 SC 14D9/A Response to a tender offer, amended
Jul 10, 2026 SC TO-T/A Tender offer, amended
Jul 2, 2026 SC 14D9/A Response to a tender offer, amended
Jun 10, 2026 SC 14D9 Response to a tender offer
Jun 10, 2026 SC TO-T Tender offer
Jun 9, 2026 SC14D9C Form SC14D9C
Jun 9, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Jun 8, 2026
Jun 1, 2026 SC TO-C Tender offer communication
Jun 1, 2026 SC14D9C Form SC14D9C
Jun 1, 2026 8-K item 8.01 Other event · Current report
May 29, 2026 SC TO-C Tender offer communication
May 29, 2026 SC14D9C Form SC14D9C
May 29, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report
May 11, 2026 10-Q Quarterly report Mar 31, 2026
May 4, 2026 SC TO-C Tender offer communication
May 4, 2026 SC14D9C Form SC14D9C
May 4, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report May 3, 2026
Apr 28, 2026 10-K/A Annual report, amended Dec 31, 2025
Apr 15, 2026 SC14D9C Form SC14D9C
Apr 15, 2026 8-K item 8.01 Other event · Current report
40 of 302 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton LSTA · research, not advice